Akebia Therapeutics Inc. sell melinda
Start price
28.04.17
/
50%
€12.05
Target price
14.09.17
€8.12
Performance (%)
32.26%
End price
14.09.17
€15.94
Summary
This prediction ended on 14.09.17 with a price of €15.94. The SELL prediction by melinda for Akebia Therapeutics Inc. was trending in the completely wrong direction and closed with a performance of 32.26%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Akebia Therapeutics Inc. | - | - | - | - |
iShares Core DAX® | -1.114% | 3.430% | 25.966% | 25.039% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% | 48.139% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% | 11.979% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% | 46.982% |
Comments by melinda for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Biopharma
Akebia Therapeutics, Inc. ist ein biopharmazeutisches Unternehmen in der Entwicklung von neuen proprietären therapeutischen Produkten beschäftigt auf der Grundlage der Biologie des Hypoxie - induzierbaren Faktors und die Vermarktung dieser Produkte für Patienten mit Nieren disease.Its Produktkandidaten, AKB-6548, ist in einer Phase 2b
(Vom Mitglied beendet)
Stopped prediction by melinda for Akebia Therapeutics Inc.
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.12
24.09.20
24.09.20
€4.00
04.11.21
04.11.21
19.81%
05.11.21
05.11.21
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€9.05
23.02.20
23.02.20
-
24.09.20
24.09.20
-76.57%
24.09.20
24.09.20
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€5.95
06.01.20
06.01.20
€9.15
23.02.20
23.02.20
52.10%
23.02.20
23.02.20
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€5.44
08.05.19
08.05.19
€6.77
30.10.19
30.10.19
-37.12%
30.10.19
30.10.19
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€7.40
10.08.18
10.08.18
€9.56
12.11.18
12.11.18
7.07%
12.11.18
12.11.18
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.94
25.02.17
25.02.17
€9.47
26.04.17
26.04.17
13.52%
26.04.17
26.04.17